ArticleFrontiers in pharmacology2025
Data mining historical Chinese medical recipe collections and nuclear receptor profiling identify plant fractions that modulate glucocorticoid receptor activity.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Glucocorticoids (GCs) play a prominent role in the management of chronic inflammatory diseases like rheumatoid arthritis and psoriatic arthritis, but their use is associated with various adverse effects. The therapeutic and adverse effects of GCs can be partly explained by modes of engagement with their target, the glucocorticoid receptor (GR). Identifying compounds that modulate GR through alternative mechanisms of action may provide a strategy to decouple therapeutic efficacy from side effects. Historical manuscripts on Chinese pharmacotherapy, which document the empirical use of natural products in treating inflammatory diseases, represent an underexplored source in drug discovery. These texts offer a historical library of plant materials and their metabolites, enabling strategic pre-selection of plant candidates for GR-targeted screening. Method: This study utilizes the Chinese Historical Healthcare Manuscripts Database, a newly compiled corpus comprising over 41,000 medical recipes from 227 historical Chinese manuscripts, to identify plant-based treatments for rheumatoid arthritis and psoriatic arthritis. Pareto front analysis, a multi-objective optimization method, was applied to 1,897 relevant recipes to identify plants that consistently ranked high across multiple metrics, suggesting their effectiveness in historical practice. The results were evaluated by comparison with modern Chinese Findings: Pareto front analysis identified 32 botanical drugs statistically associated with historical disease indications resembling rheumatoid arthritis, psoriatic arthritis, and psoriasis. Nineteen of these are explicitly described in Chinese Conclusion: This study illustrates how combining data mining of historical pharmaceutical recipes with molecular screening can accelerate the discovery of new and possibly safer GR modulators. Such approaches may inform future translational strategies for treating chronic inflammatory diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.